glp-1 gastrointestinal obstruction law office in louisiana semaglutide firm Weight Loss Drug Attorneys: Legal Help for Injury Claims Patients claim blindness, bowel injuries
Description
I have previously summarised the therapeutic pipeline for MASH (see links below) and in the past year we have seen the approval of Resmetirom, and now Semaglutide / ozempic is showing very impressive data in a Ph3 trial

University of Cincinnati researchers, funded by the NIH, are studying how GLP-1 drugs may help prevent Alzheimers disease by analyzing real-world data from patients with mild cognitive impairment

Patients taking a placebo experienced a reduction of less than 10 percent.

An honest comparison of taste, sourcing, GLP-1 claims, and a faster real option.

Cholestyramine is a bile acid sequestering agent that was approved by the FDA for use in hyperlipidemia (high cholesterol)
